北美免疫组织化学市场预测至 2028 年 - 按应用(诊断和药物测试)、产品(抗体、设备、试剂和试剂盒)和最终用户(医院和诊断实验室、研究机构等)划分的 COVID-19 影响和区域分析)

TIPRE00025750 | Pages: 150 | Biotechnology | Nov 2021 | Type: Regional | Status: Published

市场介绍

北美是免疫组化最大的市场,美国、加拿大和墨西哥是该市场的主要贡献者在这个地区。美国在预测期内引领市场。美国免疫组织化学市场的增长归因于该国癌症等慢性病发病率的迅速增加,以及诊断需求的不断增长。免疫组织化学 (IHC) 是一种广泛使用的癌症诊断技术;它选择性地识别生物组织中的癌症标记物。例如,在乳腺癌中,免疫组织化学可定量雌激素受体、孕激素受体、人表皮生长因子受体 2、Ki-67 和 p53。据乳腺癌组织称,2019 年美国女性中估计将诊断出 268,600 例新的浸润性乳腺癌病例,大约将诊断出 62,930 例新的非浸润性(原位)乳腺癌病例。因此,随着乳腺癌变得更加普遍,对免疫组织化学的需求可能会增加。此外,该技术还用于诊断其他类型的癌症,例如前列腺癌和肺癌。据美国国家癌症研究所称,2021年该国将新增1,735,350例癌症病例。乳腺癌、肺癌和支气管癌、前列腺癌、结肠癌和直肠癌、黑色素瘤和肝癌是最常见的癌症类型。该国癌症发病率正以惊人的速度增加,导致对癌症诊断的需求增加。慢性病和传染病的发病率不断上升,生物技术和研发投资不断增加生物制药公司是推动北美免疫组化市场增长的主要因素。

北美国家,尤其是美国,因COVID-19疫情而受到严重影响。全国各地的各个医疗保健研究中心都专注于 COVID-19 的治疗。由于封锁、旅行禁令和企业停业,疫情大流行对各国经济和行业造成了不利影响。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着疫情的发展,医疗保健行业的增长预计将下降。由于北美对体外诊断产品的需求不断增加以及研发活动不断增加,生命科学领域蓬勃发展。然而,由于疫情期间进行的手术数量减少以及设备采购的延迟或延长,医疗技术和影像领域的销售额出现下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断和随后的药物上市延迟预计将为未来的完全虚拟试验铺平道路。 mRNA 等新技术有望推动制药行业的发展。因此,预计未来几年市场将出现垂直整合和合资企业。

市场概况和动态

北美免疫组化市场预计将从2021年的83805万美元增长到2028年的140586万美元;预计 2021 年至 2028 年复合年增长率为 7.7%。该地区的新兴市场正在为主要市场参与者创造巨大的业务扩展机会。这可能是未来几年推动市场增长的主要因素。由于该地区有大量人口患有慢性病,因此大多数参与者都集中在发展中市场。随着生产成本不断上升,医疗保健公司正在努力产生足够的收入来招待投资者。一些发展中经济体的市场预计将成为主要参与者扩大其行业范围提供更可靠和更有利可图的增长机会的重要组成部分。生物技术的进步增加了医疗保健市场对诊断的需求,鼓励引入更多数量的免疫分析系统并促进向个性化医疗的转变。新兴国家在传染病检测、分子肿瘤学和药物基因组学方面存在新的机遇。因此,医疗保健公司可以瞄准该地区的患者或消费者。过去几年,各国的医疗保健支出有所增加。该行业的各个参与者一直将大量收入投入到研发活动中,以开发用于医疗保健行业的更好、更先进的产品和技术。该地区重要生物制药公司的存在以及本地公司数量的不断增加是促进该地区市场增长的因素。该地区的这些活动增加了对免疫组织化学的需求。因此,新兴国家传染病发病率的上升和进展可能会提振市场,并预计在预测期内为北美市场的参与者提供重大的增长机会。

< strong>主要细分市场

从产品来看,2020年抗体细分市场占据北美免疫组化市场最大份额。从应用来看,诊断细分市场在 2020 年北美免疫组织化学市场中占据了更大的市场份额。此外,医院和诊断实验室细分市场在 2020 年基于最终用户的北美免疫组织化学市场中占据了更大的份额。

主要来源和上市公司

准备本北美免疫组织化学市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有 Abcam plc;安捷伦科技公司;生物SB;生物拉德实验室有限公司;细胞信号技术公司;丹纳赫; F. 霍夫曼拉罗什有限公司;默克公司;珀金埃尔默公司;和 THERMO FISHER SCIENTIFIC INC

购买报告的理由

  • 了解北美免疫组织化学市场格局,并确定最有可能保证强劲回报的细分市场
  • 通过了解不断变化的趋势,在竞争中保持领先地位改变北美免疫组织化学市场的竞争格局
  • 通过确定最有希望销售的细分市场,有效规划北美免疫组织化学市场的并购和合作伙伴交易
  • 帮助获得知识丰富的业务通过对北美免疫组化市场各个细分市场表现的敏锐和全面分析来做出决策
  • 获得北美地区2021-2028年各个细分市场的市场收入预测

北美免疫组织化学市场细分
北美免疫组织化学市场 - 按产品

  • 设备
    • 载玻片染色系统
    • 组织微阵列系统
    • 组织处理系统
    • 玻片扫描仪
    • 其他设备
  • 抗体
    • 一抗
    • 二抗
  • 试剂
    • 组织学染色
    • 封闭和固定试剂
    • 显色底物
    • 固定试剂
    • li>
    • 稳定剂
    • 有机溶剂
    • 蛋白水解酶
    • 稀释剂
  • 试剂盒
  • li>

北美免疫组织化学市场 - 按应用

  • 诊断
    • 癌症
    • 传染病
    • 自身免疫性疾病
    • 糖尿病
    • 肾脏疾病
    • li>
    • 其他
  • 药物测试

北美免疫组化市场 - 最终用户

  • 医院和诊断实验室
  • 研究机构
  • 其他

北美免疫组织化学市场 - 按国家/地区

  • 美国
  • 加拿大
  • 墨西哥

北美免疫组织化学市场 - 公司简介

  • Abcam plc
  • 安捷伦科技公司
  • Bio SB
  • BIO-RAD LABORATORIES INC.
  • Cell Signaling Technology, Inc.
  • 丹纳赫
  • F. HOFFMANN-LA ROCHE LTD.
  • MERCK KGaA
  • PerkinElmer Inc.
  • Thermo FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        North America Immunohistochemistry Market – By Product

1.3.2        North America Immunohistochemistry Market – By Application

1.3.3        North America Immunohistochemistry Market – By End User

1.3.4        North America Immunohistochemistry Market – By Country

2.             Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             North America Immunohistochemistry Market – Market Landscape

4.1       Overview

4.2       North America PEST Analysis

4.3       Experts Opinion

5.             North America Immunohistochemistry Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Growing Incidences of Chronic and Infectious Diseases

5.1.2        Rising R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2       Key Market Restraints

5.2.1        Complexities Associated with Immunohistochemistry

5.3       Key Market Opportunities

5.3.1        Growth Opportunities in Several Countries

5.4       Future Trends

5.4.1        Rise of Automation in Immunohistochemistry

5.5       Impact Analysis

6.             Immunohistochemistry Market – North America Analysis

6.1       North America Immunohistochemistry Market Revenue Forecast and Analysis

7.             North America Immunohistochemistry Market Analysis– By Product

7.1       Overview

7.2       North America Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3       Antibodies

7.3.1        Overview

7.3.2        Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3        Primary Antibodies

7.3.3.1      Overview

7.3.3.2      Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4        Secondary Antibodies

7.3.4.1      Overview

7.3.4.2      Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4       Equipment Market

7.4.1        Overview

7.4.2        Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3        Slide Staining Systems

7.4.3.1      Overview

7.4.3.2      Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4        Tissue Microarrays

7.4.4.1      Overview

7.4.4.2      Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5        Tissue Processing Systems

7.4.5.1      Overview

7.4.5.2      Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6        Slide Scanners

7.4.6.1      Overview

7.4.6.2      Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7        Other Equipments

7.4.7.1      Overview

7.4.7.2      Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5       Reagents Market

7.5.1        Overview

7.5.2        Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3        Histological Stains

7.5.3.1      Overview

7.5.3.2      Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4        Blocking Sera & Reagents Market

7.5.4.1      Overview

7.5.4.2      Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5        Chromogenic Substrates Market

7.5.5.1      Overview

7.5.5.2      Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6        Stabilizers

7.5.6.1      Overview

7.5.6.2      Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7        Proteolytic Enzymes

7.5.7.1      Overview

7.5.7.2      Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8        Organic Solvents

7.5.8.1      Overview

7.5.8.2      Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9        Fixation Reagents

7.5.9.1      Overview

7.5.9.2      Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10     Diluents

7.5.10.1    Overview

7.5.10.2    Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6       Kits Market

7.6.1        Overview

7.6.2        Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8.             North America Immunohistochemistry Market Analysis – By Application

8.1       Overview

8.2       North America Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3       Diagnostics

8.3.1        Overview

8.3.2        Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3        Cancer

8.3.3.1      Overview

8.3.3.2      Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4        Infectious Diseases

8.3.4.1      Overview

8.3.4.2      Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5        Autoimmune Diseases

8.3.5.1      Overview

8.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6        Diabetes Mellitus

8.3.6.1      Overview

8.3.6.2      Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7        Nephrological Diseases

8.3.7.1      Overview

8.3.7.2      Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8        Others

8.3.8.1      Overview

8.3.8.2      Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4       Drug Testing

8.4.1        Overview

8.4.2        Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9.             North America Global Immunohistochemistry Market Analysis– By End User

9.1       Overview

9.2       North America Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3       Hospital & Diagnostic Laboratories

9.3.1        Overview

9.3.2        Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4       Research Institutes

9.4.1        Overview

9.4.2        Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5       Others

9.5.1        Overview

9.5.2        Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.          North America Immunohistochemistry Market – Country Analysis

10.1    North America Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1     North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1    US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1    US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2    US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1        US Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.1.2.2        US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3        US Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.1.3    US Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.3.1        US Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.1.4    US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.2    Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1    Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2    Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1        Canada Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.2.2.2        Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3        Canada Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.2.3    Canada Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.3.1        Canada Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.2.4    Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.3    Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1    Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2    Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1        Mexico Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.3.2.2        Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3        Mexico Antibodies Market Revenue and Forecasts To 2028, By Type (US$ Mn)

10.1.1.3.3    Mexico Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.3.1        Mexico Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.3.4    Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11.          Impact Of COVID-19 Pandemic on North America Immunohistochemistry Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic developments

12.3.1     Overview

13.          Company Profiles

13.1    Cell Signaling Technology, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    F. HOFFMANN-LA ROCHE LTD.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    MERCK KGaA

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    PerkinElmer Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    THERMO FISHER SCIENTIFIC INC.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Abcam plc

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Agilent Technologies, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    BIO-RAD LABORATORIES INC.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Danaher

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Bio SB

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             North America Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3.             US Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4.             US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5.             US Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6.             US Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7.             US Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 8.             US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9.             Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10.          Canada Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11.          Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12.          Canada Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13.          Canada Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14.          Canada Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 15.          Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16.          Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17.          Mexico Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18.          Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19.          Mexico Antibodies Market Revenue and Forecasts to 2028, By Type (US$ Mn)

Table 20.          Mexico Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21.          Mexico Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 22.          Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23.          Organic Developments Done By Companies

Table 24.          Inorganic developments done by Companies

Table 25.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Immunohistochemistry Market Segmentation

Figure 2.           North America Immunohistochemistry Market Segmentation, By Country

Figure 3.           North America Immunohistochemistry Market Overview

Figure 4.           Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5.           The US to Show Significant Growth During Forecast Period

Figure 6.           North America PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to North America Immunohistochemistry Market

Figure 8.           North America Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9.           North America Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10.        North America Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        North America Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        North America Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        North America Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        North America Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        North America Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        North America Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        North America Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        North America Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        North America Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        North America Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        North America Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        North America Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        North America Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        North America Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        North America Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        North America Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        North America Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        North America Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        North America Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30.        North America Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31.        North America Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32.        North America Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33.        North America Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34.        North America Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35.        North America Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36.        North America Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37.        North America Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38.        North America Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39.        North America Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        North America Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41.        North America Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42.        North America Immunohistochemistry Market Revenue Overview, by Country (2021) (US$ Mn)

Figure 43.        North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44.        US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45.        Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46.        Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47.        Impact of COVID-19 Pandemic in North American Country Markets

  1. Abcam plc
  2. Agilent Technologies, Inc.
  3. Bio SB
  4. BIO-RAD LABORATORIES INC.
  5. Cell Signaling Technology, Inc.
  6. Danaher
  7. F. HOFFMANN-LA ROCHE LTD.
  8. MERCK KGaA
  9. PerkinElmer Inc.
  10. THERMO FISHER SCIENTIFIC INC.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America immunohistochemistry market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000